TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MedAdvisor Limited ( (AU:MDR) ) has issued an update.
MedAdvisor Limited announced the cessation of Jim Xenos as a director, effective from August 29, 2025. This change in the board may impact the company’s strategic direction and stakeholder relations, given Mr. Xenos’s significant interests in the company, including 42,857 fully paid ordinary shares and 500,000 unlisted options.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, focusing on providing digital medication management solutions. The company offers services that help patients manage their medication schedules and improve adherence, targeting both individual users and healthcare providers.
Average Trading Volume: 994,393
Technical Sentiment Signal: Sell
Current Market Cap: A$32.51M
Learn more about MDR stock on TipRanks’ Stock Analysis page.